Breakthrough paper on Ebola virus
July 9th, 2008Researchers have determined the crystal structure of the Ebola virus surface protein that binds host cells. The paper is a "breakthrough"
Researchers have determined the crystal structure of the Ebola virus surface protein that binds host cells. The paper is a "breakthrough"
Stem cell prospects dim in NJ. Without funds, plans for a new state stem cell institute were recently canned and an empty lot now sits where the research hub might have been.
Sphere: Related ContentA fascinating look into culture, a basic biological entity. Culture - selected for survival of the genome.
A prominent neuroscientist is accusing two former researchers in his lab of taking data without his permission and publishing misleading interpretations of them against his wishes.
Sphere: Related ContentAs I sit here on a overcast 4th of July, I stumbled acrossed ESPN’s coverage of Nathan’s hot dog eating competition. It seems interesting enough - 20+ eaters enter a competition to crown the one true great eater. As the contestants enter, I was surprised how many of them were skinny! That\\\\\\\’s right - the greatest eater is not even a fat man.
Sphere: Related ContentWhat genes contribute to social interactions such as cheating or altruism? And what could cheating genes tell us about sociality, multicellularity, and cancer? A social soil amoeba could hold the answers.
Sphere: Related ContentThis is kind of disturbing. Sure at first they will use cancer patients and burn victims to gain approval, but we all know it will not stop there. Before we know it girls everywhere will be attending bio-beauty parties. Somehow I don’t think stem cells where intended for beautification of oneself.
Sphere: Related ContentI’m appalled that Kogene Biotech let disgraced frauds such as Hwang Woo-suk still work in the field of stem cells and cloning. To me faking results should mean expulsion from the field.
Sphere: Related ContentWelcome to Newscloud.com. This is your first post. Edit or delete it, then start blogging!
GlaxoSmithKline, marketers of the over-the-counter weight-loss drug alli, which we profiled in last month’s issue, is asking the FDA to force weight-loss supplement sellers to conduct clinical trials on their products. With fewer supplements on the market, GSK would face significantly less competition for its product, which the company hopes to turn into profit
Sphere: Related Content